Literature DB >> 15656597

Conjugation of DOTA using isolated phenolic active esters: the labeling and biodistribution of albumin as blood pool marker.

Walter Mier1, Johannes Hoffend, Susanne Krämer, Jochen Schuhmacher, William E Hull, Michael Eisenhut, Uwe Haberkorn.   

Abstract

A convenient method for the functionalization of proteins with DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) has been developed. For this purpose DOTA was converted into a series of different monoreactive activated phenolic esters. The esters were prepared in a single step from commercially available DOTA, using 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide or 1,3-dicyclohexylcarbodiimide as coupling agent. The resulting activated esters were isolated by HPLC, lyophilized, and stored for future applications. In solid form the compounds exhibit high hydrolytic stability. The reactions with proteins proceeded in good yields. The conjugation and subsequent radiolabeling of the 4-nitrophenol ester of DOTA with 67Ga was investigated with rat serum albumin. A time-dependent biodistribution study in tumor bearing rats was conducted to demonstrate the integrity of the albumin conjugate. These results suggest that phenolic esters of DOTA represent versatile reagents to conjugate DOTA with proteins and other biomolecules in high yields.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15656597     DOI: 10.1021/bc034216c

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  10 in total

1.  Identification of a novel short peptide seal specific to CD59 and its effect on HeLa cell growth and apoptosis.

Authors:  Bing Li; Mei-Hua Gao; Xian-Ming Chu; Ying-Jie Xu; Fan Yang
Journal:  Cell Oncol (Dordr)       Date:  2012-09-04       Impact factor: 6.730

Review 2.  Clinical applications of Gallium-68.

Authors:  Sangeeta Ray Banerjee; Martin G Pomper
Journal:  Appl Radiat Isot       Date:  2013-02-20       Impact factor: 1.513

Review 3.  Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy.

Authors:  Zhibo Liu; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2016-03-07       Impact factor: 54.564

4.  Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies.

Authors:  Matthias Eder; Björn Wängler; Stefan Knackmuss; Fabrice LeGall; Melvyn Little; Uwe Haberkorn; Walter Mier; Michael Eisenhut
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-29       Impact factor: 9.236

5.  High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a (177)Lu-based CD22-specific radioimmunoconjugate and rituximab.

Authors:  Tobias Weber; Benedikt Bötticher; Walter Mier; Max Sauter; Susanne Krämer; Karin Leotta; Armin Keller; Anne Schlegelmilch; Ludger Grosse-Hovest; Dirk Jäger; Uwe Haberkorn; Michaela A E Arndt; Jürgen Krauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-04       Impact factor: 9.236

6.  A quinazoline-derivative DOTA-type gallium(III) complex for targeting epidermal growth factor receptors: synthesis, characterisation and biological studies.

Authors:  Raquel Garcia; Petra Fousková; Lurdes Gano; António Paulo; Paula Campello; Eva Tóth; Isabel Santos
Journal:  J Biol Inorg Chem       Date:  2008-11-13       Impact factor: 3.358

7.  Radioimmunotheranostic Pair Based on the Anti-HER2 Monoclonal Antibody: Influence of Chelating Agents and Radionuclides on Biological Properties.

Authors:  Ana Cláudia Camargo Miranda; Sofia Nascimento Dos Santos; Leonardo Lima Fuscaldi; Luiza Mascarenhas Balieiro; Maria Helena Bellini; Maria Inês Calil Cury Guimarães; Elaine Bortoleti de Araújo
Journal:  Pharmaceutics       Date:  2021-06-27       Impact factor: 6.321

8.  FAP-Specific Signalling Is an Independent Diagnostic Approach in ACC and Not a Surrogate Marker of MRI Sequences.

Authors:  Dawn P Liew; Manuel Röhrich; Lisa Loi; Sebastian Adeberg; Mustafa Syed; Ewgenija Gutjahr; Heinz Peter Schlemmer; Frederik L Giesel; Martin Bendszus; Uwe Haberkorn; Daniel Paech
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

9.  An efficient targeted drug delivery through apotransferrin loaded nanoparticles.

Authors:  Athuluri Divakar Sai Krishna; Raj Kumar Mandraju; Golla Kishore; Anand Kumar Kondapi
Journal:  PLoS One       Date:  2009-10-02       Impact factor: 3.240

10.  Is nano too big?

Authors:  Walter Mier; John Babich; Uwe Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01       Impact factor: 9.236

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.